Transitioning from Discovery to Pre-IND: Key Steps and Insights
Discover essential insights on the transition from discovery to pre-IND. Explore our comprehensive guide for valuable information.
Drug Development Acceleration Strategies for Phase 2
Discover essential insights on drug development strategies for phase 2. Explore our comprehensive guide for valuable information.
Upperton Invests in Dual Fill-2-Weight Capability and Two New Microfluidizers
Upperton advances sterile manufacturing facility following MHRA submission.
Upperton Shortlisted in Five Categories at Pharma Industry Awards UK 2026
Upperton advances sterile manufacturing facility following MHRA submission.
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy
Upperton advances sterile manufacturing facility following MHRA submission.
Risk Isn’t Inevitable: How the Right CDMO Partnership Protects Your Programme
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
How Upperton Has Evolved to Meet the Changing Needs of Biotechs
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
DDL 2025 – The Next Chapter in Inhalation
• The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
The Evolution of Biotech and CDMO Partnerships
• The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
Does a One-Site CDMO Make a Difference in Drug Development?
A one-site CDMO is where GMP, R&D and manufacturing all operate on one site, making the movement of projects streamlined.